Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study ; volume:12 ; number:3 ; day:9 ; month:2 ; year:2021 ; pages:801-811 ; date:3.2021
Diabetes therapy ; 12, Heft 3 (9.2.2021), 801-811, 3.2021
- Creator
-
Williams, David M.
Ruslan, Aliya M.
Khan, Rahim
Vijayasingam, Daneeshanan
Iqbal, Fizzah
Shaikh, Ayesha
Lim, Jia
Chudleigh, Richard
Peter, Rajesh
Udiawar, Maneesh
Bain, Stephen C.
Stephens, Jeffrey W.
Min, Thinzar
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-021-01015-z
- URN
-
urn:nbn:de:101:1-2021040119170212696087
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Williams, David M.
- Ruslan, Aliya M.
- Khan, Rahim
- Vijayasingam, Daneeshanan
- Iqbal, Fizzah
- Shaikh, Ayesha
- Lim, Jia
- Chudleigh, Richard
- Peter, Rajesh
- Udiawar, Maneesh
- Bain, Stephen C.
- Stephens, Jeffrey W.
- Min, Thinzar
- SpringerLink (Online service)
Other Objects (12)
Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study
Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study
Semaglutide
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study
Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study
Real-World Use of Oral and Subcutaneous Semaglutide in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study
Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study
Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)
PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice
Real-world use of once-weekly semaglutide in type 2 diabetes: results from SURE Germany
Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population
Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study
Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study
Semaglutide
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study
Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study
Real-World Use of Oral and Subcutaneous Semaglutide in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study
Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study
Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)
PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice
Real-world use of once-weekly semaglutide in type 2 diabetes: results from SURE Germany
Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population
Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study
Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study
Semaglutide
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study
Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study
Real-World Use of Oral and Subcutaneous Semaglutide in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study
Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study
Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)
PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice
Real-world use of once-weekly semaglutide in type 2 diabetes: results from SURE Germany